Rigel Pharmaceuticals

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell RIGL and other ETFs, options, and stocks.

About RIGL

Rigel Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It discovers and develops novel, targeted drugs in the therapeutic areas of immunology, oncology and immune oncology.

CEO

Raul R. Rodriguez

CEORaul R. Rodriguez

Employees

147

Employees147

Headquarters

South San Francisco, California

HeadquartersSouth San Francisco, California

Founded

1996

Founded1996

Employees

147

Employees147

RIGL Key Statistics

Market cap

190.29M

Market cap190.29M

Price-Earnings ratio

-7.55

Price-Earnings ratio-7.55

Dividend yield

—

Dividend yield—

Average volume

1.96M

Average volume1.96M

High today

$1.11

High today$1.11

Low today

$1.05

Low today$1.05

Open price

$1.06

Open price$1.06

Volume

742.99K

Volume742.99K

52 Week high

$1.96

52 Week high$1.96

52 Week low

$0.712

52 Week low$0.712

RIGL News

Simply Wall St 11h

Little Excitement Around Rigel Pharmaceuticals, Inc.'s Revenues As Shares Take 29% Pounding - Simply Wall St

Rigel Pharmaceuticals, Inc. ( ) shareholders won't be pleased to see that the share price has had a very rough month, dropping 29% and undoing the prior period'...

Yahoo Finance 2d

Rigel Pharmaceuticals May Report Negative Earnings: Know the Trend Ahead of Q1 Release - Yahoo Finance

Rigel Pharmaceuticals (RIGL) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March...

Yahoo Finance 2d

Rigel Announces Conference Call and Webcast to Report First Quarter 2024 Financial Results and Business Update - Yahoo Finance

SOUTH SAN FRANCISCO, Calif., April 30, 2024 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it will report its first quarter 202...

Analyst ratings

67%

of 6 ratings

Buy

33.3%

Hold

66.7%

Sell